Dixon Hubard Feinour & Brown’s Celgene Corp CELG Stock Holding History

Dixon Hubard Feinour & Brown’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-44,562	Closed	-$6.5M	–	204
2017 Q3	$6.5M	Buy	44,562 +42,700	+2,293%	+$5.82M	1.87%	16
2017 Q2	$242K	Hold	1,862	–	–	0.07%	157
2017 Q1	$232K	Hold	1,862	–	–	0.07%	156
2016 Q4	$216K	Sell	1,862 -200	-10%	-$22.3K	0.07%	155
2016 Q3	$216K	Hold	2,062	–	–	0.07%	161
2016 Q2	$203K	Hold	2,062	–	–	0.06%	160
2016 Q1	$213K	Hold	2,062	–	–	0.07%	159
2015 Q4	$247K	Hold	2,062	–	–	0.08%	142
2015 Q3	$223K	Buy	2,062 +60	+3%	+$7.45K	0.08%	141
2015 Q2	$232K	Hold	2,002	–	–	0.07%	157
2015 Q1	$231K	Hold	2,002	–	–	0.07%	176
2014 Q4	$224K	Buy	+2,002	New	+$211K	0.07%	175

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dixon Hubard Feinour & Brown's CELG Position: Q4 2017 in Review

Dixon Hubard Feinour & Brown sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 44,562 shares — an estimated $6.5M sold.

Dixon Hubard Feinour & Brown first reported a position in CELG in Q4 2014 and held it in 12 quarters. The position peaked at $6.5M in Q3 2017. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

Dixon Hubard Feinour & Brown reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
Dixon Hubard Feinour & Brown sold 44,562 Celgene Corp shares in Q4 2017, an estimated $6.5M.
Dixon Hubard Feinour & Brown first reported a position in Celgene Corp in Q4 2014 and held it in 12 quarters.
Dixon Hubard Feinour & Brown's Celgene Corp position peaked at $6.5M in Q3 2017.
1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q4 2017, filed 20 Feb 2018.